TAVI is recommended in patients in intermediate risk group in updated Sweden national guideline

At the end of June of 2018, the National Board of Health and Welfare (Socialtyrelsen) has published an updated version of the National clinical guidelines for heart care. The review of the guidelines was conducted in order to include few updated recommendations regarding:

• the use of medication for the treatment arrhythmia;
• the use of medical devices for the treatment of valvular heart disease:
  • transcatheter aortic valve implantation (TAVI) should be offered in patients with severe symptomatic aortic stenosis and the following risk profiles:
    • inoperable patients (priority level 3);
    • patients with high surgical risk (priority level 4);
    • patients with intermediate surgical risk (priority level 4).

Three new recommendations in relation to medication for the treatment of coronary heart disease were also provided.

See the summary of all changes in Swedish here.

See full information in Swedish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.